Major depression
RecruitingA study to evaluate the effectiveness and safety of DT-101 in adults with major depressive disorder
- Disease:Major depression
- Substances:–
Bulgaria- Participants:18–64 years · 65+ years
- Sponsor:Draig Therapeutics Limited
Rare diseases
Investigational molecules
Locations
Sbarc Spark, Maindy Road, CF24 4HQ, United Kingdom
Draig Therapeutics Limited is involved in clinical research focused on Major Depressive Disorder, with an emphasis on treatment options for depressive symptoms in adults.
The sponsor’s research activity is centred on therapeutic development for mood disorders and related psychiatric care.
Draig Therapeutics Limited runs clinical trials in conditions such as Major depression, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BulgariaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.